This research project addresses the structure-function properties and signaling pathways of the AT1 receptor, which mediates the physiological actions of angiotensin II (Ang II) in the cardiovascular system, adrenal, kidney, brain, liver, and other target tissues. In addition to its specific roles in Ang II target cells, the AT1 receptor serves as a model for the function of other G protein coupled receptors (GPCRs). Our analysis of the roles of specific amino acids in AT1 receptor function has identified residues involved in ligand binding, receptor activation, G protein coupling, and receptor internalization. Recent examples include the importance of two seventh transmembrane domain asparagine, Asn294 and Asn295, in receptor activation and ligand binding, respectively. Also, membrane-proximal amino acids in the carboxyterminal cytoplasmic domain, in particular Phe301, were found to be significant determinants of receptor expression at the cell surface. Some of the functions of GPCRs known to be regulated by agonist-induced phosphorylation of serine/threonine residues in the cytoplasmic tail and/or intracellular loops of the receptor. A highly specific antibody to the AT1 receptor was raised against a fusion protein containing the 92-amino acid C-terminal fragment of the receptor. This antibody permitted the analysis of agonist-induced phosphorylation in the native AT1 receptor immunoprecipitated from Ang II-treated bovine adrenal glomerulosa cells. Receptor phosphorylation was rapid, and was correlated with the degree of ligand occupancy of the receptor. The AT1 receptor was also phosphorylated by activation of protein kinases A and C, but to a lesser extent than that induced by Ang II. Inhibition of PKC activity by stauresporine abolished TPA-induced receptor phosphorylation but enhanced Ang II-induced phosphorylation. This suggests that PKC may exert an inhibitory action on the G protein receptor kinases that are regarded as the major mediators of agonist-induced receptor phosphorylation. An investigation of the sites at which the AT1 receptor is phosphorylated was performed on mutant receptors bearing deletions or mutations in the cytoplasmic tail. This study utilized epitope-tagged AT1 receptors that were expressed in COS cells and immunoprecipitated with an anti-HA antibody after agonist stimulation. The Ang II-induced phosphorylation of the AT1 receptor was found to be confined to an 11-amino acid serine/threonine-rich region in the C-terminal cytoplasmic tail, indicating the importance of this region in receptor internalization and

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Intramural Research (Z01)
Project #
1Z01HD000193-13
Application #
6107983
Study Section
Special Emphasis Panel (ERRB)
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1998
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Choi, Hyun; Leto, Thomas L; Hunyady, Laszlo et al. (2008) Mechanism of angiotensin II-induced superoxide production in cells reconstituted with angiotensin type 1 receptor and the components of NADPH oxidase. J Biol Chem 283:255-67
Yin, Xing; Li, Bo; Chen, Hungdar et al. (2008) Differential signaling pathways in angiotensin II- and epidermal growth factor-stimulated hepatic C9 cells. Mol Pharmacol 74:1223-33
Chow, L; Rezmann, L; Imamura, K et al. (2008) Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines. Prostate 68:651-60
Louis, Simon N; Wang, Lin; Chow, Laurie et al. (2007) Appearance of angiotensin II expression in non-basal epithelial cells is an early feature of malignant change in human prostate. Cancer Detect Prev 31:391-5
Shah, Bukhtiar H; Neithardt, Adrienne; Chu, David B et al. (2006) Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs. J Cell Physiol 206:47-57
Hunyady, Laszlo; Catt, Kevin J (2006) Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol 20:953-70
Shah, Bukhtiar H; Catt, Kevin J (2006) TACE-dependent EGF receptor activation in angiotensin-II-induced kidney disease. Trends Pharmacol Sci 27:235-7
Nikiforovich, Gregory V; Zhang, Meng; Yang, Qing et al. (2006) Interactions between conserved residues in transmembrane helices 2 and 7 during angiotensin AT1 receptor activation. Chem Biol Drug Des 68:239-49
Chen, Jianguang; Kinyamu, H Karimi; Archer, Trevor K (2006) Changes in attitude, changes in latitude: nuclear receptors remodeling chromatin to regulate transcription. Mol Endocrinol 20:1-13
Shah, Bukhtiar H; Shah, Farzana B; Catt, Kevin J (2006) Role of metalloproteinase-dependent EGF receptor activation in alpha-adrenoceptor-stimulated MAP kinase phosphorylation in GT1-7 neurons. J Neurochem 96:520-32

Showing the most recent 10 out of 37 publications